Stephane Bancel Moderna, Inc. (MRNA) insider trading activity

Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $216 Million. The most recent transaction as insider was on Jun 14, 2024, when has been sold 26,840 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M

0% 3M change

1.05% 12M change

Total Value Held $216 Million

Stephane Bancel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 14 2024	BUY Other acquisition or disposition	-	26,840 Added 0.49%	5,487,064 Common Stock
Feb 16 2024	SELL Open market or private sale	$2,342,076 $88.88 p/Share	26,351 Reduced 0.48%	5,460,224 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	56,736 Added 1.02%	5,486,575 Common Stock
Sep 15 2023	BUY Other acquisition or disposition	-	17,893 Added 0.33%	5,429,839 Common Stock
Jun 28 2023	SELL Open market or private sale	$3,305,035 $121.71 p/Share	27,155 Reduced 0.5%	5,411,946 Common Stock
Jun 28 2023	BUY Exercise of conversion of derivative security	$26,883 $0.99 p/Share	27,155 Added 0.5%	5,439,101 Common Stock
Jun 22 2023	SELL Open market or private sale	$4,780,000 $119.5 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 22 2023	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 21 2023	SELL Open market or private sale	$4,879,600 $121.99 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 21 2023	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 15 2023	SELL Open market or private sale	$5,116,000 $127.9 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 15 2023	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 14 2023	SELL Open market or private sale	$5,048,800 $126.22 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 14 2023	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 08 2023	SELL Open market or private sale	$4,977,600 $124.44 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 08 2023	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 07 2023	SELL Open market or private sale	$5,044,800 $126.12 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 07 2023	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 01 2023	SELL Open market or private sale	$5,088,800 $127.22 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
May 31 2023	SELL Open market or private sale	$5,083,600 $127.09 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
May 31 2023	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
May 25 2023	SELL Open market or private sale	$5,110,800 $127.77 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
May 25 2023	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
May 24 2023	SELL Open market or private sale	$5,280,400 $132.01 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock

Stephane Bancel

Chief Executive Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account